INMED PHARMACEUTICALS INC's ticker is and the CUSIP is 457637601. A total of 10 filers reported holding INMED PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 15,284 | $101,000 | 0.13% |
| ARMISTICE CAPITAL, LLC | 90,000 | $593,000 | 0.01% |
| ROYAL BANK OF CANADA | 9 | $0 | 0.00% |
| TCI Wealth Advisors, Inc. | 5 | $0 | 0.00% |
| UBS Group AG | 5,797 | $38,000 | 0.00% |
| AllSquare Wealth Management LLC | 21 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 76 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6,770 | $45,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 13,922 | $91,000 | 0.00% |